Department of Oral Diseases, Turku University Hospital, Turku, Finland.
Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Turku, Finland.
Eur J Pain. 2019 Jul;23(6):1153-1161. doi: 10.1002/ejp.1382. Epub 2019 Mar 12.
Neuropathic mechanisms are involved in burning mouth syndrome (BMS), and variation of the dopamine D2 receptor (DRD2) gene contributes to experimental pain perception. We investigated whether neurophysiologic findings differ in BMS patients compared to healthy controls, and whether 957C>T polymorphism of the DRD2 gene influences thermal sensitivity or pain experience in BMS.
Forty-five BMS patients (43 women), mean age 62.5 years, and 32 healthy controls (30 women), mean age 64.8 years, participated. Patients estimated pain intensity, interference, suffering and sleep with Numeric Rating Scale. Blink reflex tests of the supraorbital (SON), mental (MN) and lingual (LN) nerves, and thermal quantitative sensory testing were done. The results were analysed with ANOVA. DRD2 gene 957C>T polymorphism was determined in 31 patients, and its effects on neurophysiologic and clinical variables were analysed.
Cool (p = 0.0090) and warm detection thresholds (p = 0.0229) of the tongue were higher in BMS patients than controls. The stimulation threshold for SON BR was higher in patients than in controls (p = 0.0056). The latencies of R2 component were longer in BMS patients than in controls (p = 0.0005) at the SON distribution. Habituation of SON BR did not differ between the groups. The heat pain thresholds were highest (p = 0.0312) in homozygous patients with 957TT, who also reported most interference (p = 0.0352) and greatest suffering (p = 0.0341). Genotype 957CC associated with sleep disturbances (p = 0.0254).
Burning mouth syndrome patients showed thermal hypoesthesia within LN distribution compatible with small fibre neuropathy. The DRD2 957C>T genotype influences perception and experience of BMS pain.
The results confirm earlier findings of neuropathic pain in BMS. The DRD2 957 C>T genotype influences perception and experience of clinical pain in BMS.
神经性机制与灼口综合征(BMS)有关,多巴胺 D2 受体(DRD2)基因的变异可影响实验性疼痛感知。我们研究了 BMS 患者与健康对照者之间神经生理发现是否存在差异,以及 DRD2 基因 957C>T 多态性是否影响 BMS 的热敏感性或疼痛体验。
45 名 BMS 患者(43 名女性,平均年龄 62.5 岁)和 32 名健康对照者(30 名女性,平均年龄 64.8 岁)参与了此项研究。患者使用数字评分量表评估疼痛强度、干扰、痛苦和睡眠。进行了眶上(SON)、精神(MN)和舌(LN)神经眨眼反射试验和热定量感觉测试。使用方差分析对结果进行分析。在 31 名患者中确定了 DRD2 基因 957C>T 多态性,并分析了其对神经生理和临床变量的影响。
与对照组相比,BMS 患者的舌冷觉(p=0.0090)和温觉检测阈值(p=0.0229)更高。SON BR 的刺激阈值在患者中高于对照组(p=0.0056)。与对照组相比,BMS 患者的 R2 成分潜伏期更长(p=0.0005)。两组之间 SON BR 的习惯化没有差异。957TT 纯合子患者的热痛阈值最高(p=0.0312),他们也报告了最大的干扰(p=0.0352)和最大的痛苦(p=0.0341)。基因型 957CC 与睡眠障碍有关(p=0.0254)。
灼口综合征患者的 LN 分布内存在热感觉迟钝,与小纤维神经病一致。DRD2 957C>T 基因型影响 BMS 疼痛的感知和体验。
研究结果证实了 BMS 中存在神经性疼痛的早期发现。DRD2 957C>T 基因型影响 BMS 临床疼痛的感知和体验。